IDEXX LABORATORIES INC /DE — Director's Dealing 2022

May 13, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2022-05-11

Reporting Person: ESSIG STUART (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-05-11	Common Stock	M	224	—	Acquired	1373	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-05-11	Non-Qualified Stock Option (right-to-buy)	$333.90	A	945	Acquired	2032-05-10	Common Stock (945)	Direct
2022-05-11	Restricted Stock Unit	$	A	344	Acquired		Common Stock (344)	Direct
2022-05-11	Restricted Stock Unit	$	M	224	Disposed		Common Stock (224)	Direct

Footnotes

F1: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2023 annual meeting of shareholders, whichever event is earlier.

F2: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. Restricted stock units vest in in one installment on the one year anniversary of the date of grant or on the date of the 2023 annual meeting of shareholders, whichever event is earlier.

F3: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These restricted stock units vested in in one installment on the one year anniversary of the date of grant or on the date of the 2022 annual meeting of shareholders, whichever event was earlier.

F4: Not applicable.